表紙:更年期障害の世界市場(2023年~2033年)
市場調査レポート
商品コード
1278366

更年期障害の世界市場(2023年~2033年)

Menopause Market Report 2023-2033

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 253 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=209.47円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

更年期障害の世界市場(2023年~2033年)
出版日: 2023年05月19日
発行: Visiongain Reports Ltd.
ページ情報: 英文 253 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の更年期障害の市場規模は、2033年までに5.4%のCAGRで成長すると予測されています。人口の高齢化、技術の進歩、医療費の増加、ライフスタイルの変化や座りがちな生活習慣の増加は、市場の成長を促進しています。

当レポートでは、世界の更年期障害市場について調査しており、市場概要、市場分析、企業プロファイルなど、包括的な情報を提供しています。

目次

第1章 レポートの概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果

第4章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 市場機会
  • COVID-19感染症の影響分析
  • ポーターのファイブフォース分析
    • サプライヤー力
    • バイヤーの力
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 新規参入業者の脅威
  • PESTLE分析

第5章 更年期障害市場分析:治療別

  • 主な調査結果
  • 治療セグメントの成長展望
  • 更年期障害市場シェア:治療別(2023年、2028年、2033年)
  • 栄養補助食品
  • 市販薬
    • ホルモン
    • 非ホルモン性
    • 抗うつ薬

第6章 更年期障害市場分析:流通チャネル別

  • 主な調査結果
  • 流通チャネルセグメントの成長展望
  • 更年期障害市場シェア:流通チャネル別(2023年、2028年、2033年)
  • 小売
  • 法人向け販売
  • オンライン

第7章 更年期障害市場分析:段階別

  • 主な調査結果
  • 段階セグメントの成長展望
  • 更年期障害市場シェア:段階別(2023年、2028年、2033年)
  • 閉経周辺期
  • 閉経
  • 閉経後

第8章 更年期障害市場分析:流通チャネル別

  • 主な調査結果
  • 流通セグメントの成長展望
  • 更年期障害市場シェア:流通チャネル別(2023年、2028年、2033年)
  • 局所
  • 注射
  • 経口

第9章 更年期障害市場分析:地域別

  • 主な調査結果
  • 地域の市場規模の推定と予測
  • COVID-19感染症の影響分析:回復シナリオ(V、U、W、L)

第10章 北米の更年期障害市場分析

第11章 欧州の更年期障害市場分析

第12章 アジア太平洋の更年期障害市場分析

第13章 ラテンアメリカの更年期障害市場分析

第14章 中東・アフリカの更年期障害市場分析

第15章 競合情勢

  • 企業シェア分析
  • 戦略的展望

第16章 企業プロファイル

  • Theramex
  • AbbVie Inc.
  • Bayer AG
  • Cipla Inc.
  • TherapeuticsMD
  • Eli Lilly and Company
  • Emcure
  • Glenmark Pharmaceuticals Limited
  • Merck &Co., Inc.
  • Novartis AG
  • Novo Nordisk A/S
  • Pure Encapsulations, LLC
  • Padagis
  • Teva Pharmaceutical Industries Ltd.
  • Abbott

第17章 結論と推奨事項

  • 結論
  • 市場参入企業への推奨事項
図表

List of Tables

  • Table 1 Menopause Market Snapshot, 2023 & 2033 (US$ Billion, CAGR %)
  • Table 2 Menopause Market by Region, 2023-2033 (US$ bn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 3 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "U" Shaped Recovery Scenario
  • Table 4 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 5 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 6 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 7 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 8 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 9 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 10 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 11 Others Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 12 Retail Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 13 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 14 Online Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 15 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 16 Menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 17 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 18 Topical Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 19 Injectable Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 20 Oral Market Forecast by Region, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 21 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
  • Table 22 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "V" Shaped Recovery Scenario
  • Table 23 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "U" Shaped Recovery Scenario
  • Table 24 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "W" Shaped Recovery Scenario
  • Table 25 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR(%)): "L" Shaped Recovery Scenario
  • Table 26 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 27 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 28 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 29 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 30 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 31 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 32 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 33 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 34 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 35 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 36 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 37 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 38 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 39 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 40 France Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 41 Italy Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 42 Spain Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 43 Russia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 44 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 45 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 46 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 47 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 48 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 49 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 50 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 51 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 52 India Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 53 Australia Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 54 South Korea Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 55 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 56 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 57 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 58 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 59 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 60 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 61 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 62 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 63 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 64 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 65 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 66 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 67 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 68 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 69 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR%, CAGR%)
  • Table 70 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 71 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR%, CAGR %)
  • Table 72 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ Bn, AGR%, CAGR %)
  • Table 73 Strategic Outlook
  • Table 74 Theramex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 Theramex: Product Benchmarking
  • Table 76 Theramex: Strategic Outlook
  • Table 77 Abbvie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 AbbVie Inc.: Product Benchmarking
  • Table 79 AbbVie Inc.: Strategic Outlook
  • Table 80 Bayer AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 Bayer AG: Product Benchmarking
  • Table 82 Cipla Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 Cipla: Product Benchmarking
  • Table 84 Cipla: Strategic Outlook
  • Table 85 TherapeuticsMD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 86 TherapeuticsMD: Product Benchmarking
  • Table 87 TherapeuticsMD: Strategic Outlook
  • Table 88 Eli Lilly and Company.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Eli Lilly and Company: Product Benchmarking
  • Table 90 Emcure.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Emcure: Product Benchmarking
  • Table 92 Glenmark Pharmaceuticals Limited.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Glenmark Pharmaceuticals Limited: Product Benchmarking
  • Table 94 Glenmark Pharmaceuticals Limited: Strategic Outlook
  • Table 95 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 96 Merck & Co. Inc.: Product Benchmarking
  • Table 97 Novartis AG.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Novartis.: Product Benchmarking
  • Table 99 Novo Nordisk A/S.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 Novo Nordisk.: Product Benchmarking
  • Table 101 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Pure Encapsulations, LLC.: Product Benchmarking
  • Table 103 Pure Encapsulations, LLC.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Padagis.: Product Benchmarking
  • Table 105 Teva Pharmaceuticals Limited.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 Teva Pharmaceuticals Limited: Product Benchmarking
  • Table 107 Teva Pharmaceuticals Limited: Strategic Outlook
  • Table 108 Abbott.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Teva Pharmaceuticals Limited: Product Benchmarking

List of Figures

  • Figure 1 Menopause Market Segmentation
  • Figure 7 Menopause Market: Market Dynamics
  • Figure 8 COVID Impact Analysis: Menopause Market Recovery Scenarios
  • Figure 9 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 10 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 11 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 12 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 13 Menopause Market: Porter's Five Forces Analysis
  • Figure 14 Menopause Market: PESTLE Analysis
  • Figure 15 Menopause Market Forecast by Type 2023, 2028, 2033 (Revenue, CAGR %)
  • Figure 16 Menopause Market Share Forecast by Treatment Type, 2023, 2028, 2033 (%)
  • Figure 17 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 18 Dietary Supplements Market Share Forecast by Region, 2023-2033 (%)
  • Figure 19 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 20 OTC Pharma Products Market Share Forecast by Region, 2023-2033 (%)
  • Figure 21 Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 22 Hormonal Market Share Forecast by Region, 2023-2033 (%)
  • Figure 23 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 24 Non-Hormonal Market Share Forecast by Region, 2023-2033 (%)
  • Figure 25 Anti-depressants Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 26 Anti-depressants Market Share Forecast by Region, 2023-2033 (%)
  • Figure 27 Others Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 28 Others Market Share Forecast by Region, 2023-2033 (%)
  • Figure 29 Menopause Market Forecast by Distribution Channel 2023, 2028, 2033 (Revenue, CAGR %)
  • Figure 30 Menopause Market Share Forecast by Distribution Channels, 2023, 2028, 2033 (%)
  • Figure 31 Retail Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 32 Retail Market Share Forecast by Region, 2023-2033 (%)
  • Figure 33 Institutional Sales Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 34 Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
  • Figure 35 Online Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 36 Online Market Share Forecast by Region, 2023-2033 (%)
  • Figure 37 Menopause Market Forecast by Stage 2023, 2028, 2033 (Revenue, CAGR %)
  • Figure 38 Menopause Market Share Forecast by Stage, 2023, 2028, 2033 (%)
  • Figure 39 Perimenopause Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 40 Perimenopause Market Share Forecast by Region, 2023-2033 (%)
  • Figure 41 Menopause Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 42 Menopause Institutional Sales Market Share Forecast by Region, 2023-2033 (%)
  • Figure 43 Post menopause Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 44 Post Menopause Market Share Forecast by Region, 2023-2033 (%)
  • Figure 45 Menopause Market Forecast by RoA 2023, 2028, 2033 (Revenue, CAGR %)
  • Figure 46 Menopause Market Share Forecast by RoA, 2023, 2028, 2033 (%)
  • Figure 47 Topical Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 48 Topical Market Share Forecast by Region, 2023-2033 (%)
  • Figure 49 Injectable Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 50 Injectable Market Share Forecast by Region, 2023-2033 (%)
  • Figure 51 Oral Market Forecast by Region, 2023-2033 (US$ billion)
  • Figure 52 Oral Market Share Forecast by Region, 2023-2033 (%)
  • Figure 53 Menopause Market Forecast by Region 2023 & 2033 (Revenue, CAGR %)
  • Figure 54 Menopause Market Share Forecast by Region 2023, 2028, 2033(%)
  • Figure 55 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%))
  • Figure 56 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "V" Shaped Recovery
  • Figure 57 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "U" Shaped Recovery
  • Figure 58 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "W" Shaped Recovery
  • Figure 59 Menopause Market by Region, 2023-2033 (US$ Bn, AGR (%), CAGR (%)): "L" Shaped Recovery
  • Figure 60 North America Menopause Market Attractiveness Index
  • Figure 61 North America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
  • Figure 62 North America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
  • Figure 63 North America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 64 North America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
  • Figure 65 North America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 66 North America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
  • Figure 67 North America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 68 North America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
  • Figure 69 North America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
  • Figure 70 North America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
  • Figure 71 North America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
  • Figure 72 U.S. Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 73 Canada Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 74 Europe Menopause Market Attractiveness Index
  • Figure 75 Europe Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 76 Europe Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
  • Figure 77 Europe Menopause Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 78 Europe Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
  • Figure 79 Europe Menopause Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 80 Europe Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
  • Figure 81 Europe Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 82 Europe Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
  • Figure 83 Europe Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
  • Figure 84 Europe Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
  • Figure 85 Europe Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
  • Figure 86 UK Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 87 Germany Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 88 France Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 89 Italy Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 90 Spain Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 91 Russia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 92 Rest of Europe Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 93 Asia Pacific Menopause Market Attractiveness Index
  • Figure 94 Asia Pacific Menopause Market by Region, 2023, 2028 & 2033 (US$ billion)
  • Figure 95 Asia Pacific Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
  • Figure 96 Asia Pacific Menopause Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 97 Asia Pacific Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
  • Figure 98 Asia Pacific Menopause Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 99 Asia Pacific Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
  • Figure 100 Asia Pacific Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 101 Asia Pacific Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
  • Figure 102 Asia Pacific Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
  • Figure 103 Asia Pacific Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
  • Figure 104 Asia Pacific Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
  • Figure 105 Japan Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 106 China Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 107 India Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 108 Australia Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 109 South Korea Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 110 Rest of Asia Pacific Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 111 Latin America Menopause Market Attractiveness Index
  • Figure 112 Latin America Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
  • Figure 113 Latin America Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
  • Figure 114 Latin America Menopause Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 115 Latin America Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
  • Figure 116 Latin America Menopause Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 117 Latin America Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
  • Figure 118 Latin America Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 119 Latin America Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
  • Figure 120 Latin America Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
  • Figure 121 Latin America Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
  • Figure 122 Latin America Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
  • Figure 123 Brazil Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 124 Mexico Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 125 Argentina Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 126 Rest of Latin America Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 127 MEA Menopause Market Attractiveness Index
  • Figure 128 MEA Menopause Market by Region, 2022, 2027 & 2032 (US$ billion)
  • Figure 129 MEA Menopause Market Forecast by Country, 2023-2033 (US$ billion, AGR %)
  • Figure 130 MEA Menopause Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 131 MEA Menopause Market Forecast by Type, 2023-2033 (US$ billion, AGR %)
  • Figure 132 MEA Menopause Market Share Forecast by Type, 2023 & 2033 (%)
  • Figure 133 MEA Menopause Market Forecast by Distribution Channel, 2023-2033 (US$ billion, AGR %)
  • Figure 134 MEA Menopause Market Share Forecast by Distribution Channel, 2023 & 2033 (%)
  • Figure 135 MEA Menopause Market Forecast by Stage, 2023-2033 (US$ billion, AGR %)
  • Figure 136 MEA Menopause Market Share Forecast by Stage, 2023 & 2033 (%)
  • Figure 137 MEA Menopause Market Forecast by RoA, 2023-2033 (US$ billion, AGR %)
  • Figure 138 MEA Menopause Market Share Forecast by RoA, 2023 & 2033 (%)
  • Figure 139 GCC Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 140 South Africa Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 141 Rest of MEA Menopause Market Forecast, 2023-2033 (US$ billion, AGR %)
  • Figure 142 Menopause Market: Company Share Analysis, 2021
  • Figure 143 Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 144 Bayer: Net Revenue, 2018-2021 (US$ million, AGR %)
  • Figure 145 Cipla: Net Revenue, 2019-2022 (US$ million, AGR %)
  • Figure 146 TherapeuticsMD: Net Revenue, 2020-2021 (US$ million, AGR %)
  • Figure 147 Eli Lily: Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 148 Emcure: Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 149 Glenmark: Net Revenue, 2019-2022 (US$ million, AGR %)
  • Figure 150 Merck: Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 151 Novartis: Net Revenue, 2020-2022 (US$ million, AGR %)
  • Figure 152 Novo Nordisk: Net Revenue, 2019-2022 (US$ million, AGR %)
  • Figure 153 Net Revenue, 2019-2021 (US$ million, AGR %)
  • Figure 154 Abbott: Net Revenue, 2019-2021 (US$ million, AGR %)
目次
Product Code: PHA1249

The global Menopause market is projected to grow at a CAGR of 5.4% by 2033.

“The Menopause Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Demand for Post-Menopause Drugs Owing to Rise in Geriatric Population

Some of the major forces propelling the menopause and post-menopause market include the aging population, rising awareness, technological advancements, and increasing healthcare spending drive demand for new and innovative solutions. With growing awareness about menopause and its symptoms, more women are seeking treatment options. The aging population is growing worldwide, and it is expected that the number of menopausal women will increase in the coming years. This presents a huge market opportunity for menopause drugs.

Lifestyles changes and sedentary habits have led to an increase in menopausal symptoms as women suffer from symptoms such as insomnia, erratic mood changes and hot flashes. This has led to a rise in demand for menopause drugs that can alleviate these symptoms. With new advancements in drug manufacturing and delivery methods, it is possible to create more effective and targeted menopause drugs with fewer side effects. Moreover, as healthcare expenditures increase globally, more women will have access to menopause drugs, which will drive the market further.

Misconceptions and Associated Side Effect Challenges to Hamper Industry Growth

Menopause is often stigmatized as a taboo subject and inadequately discussed. Women may feel embarrassed and uncomfortable discussing their symptoms, leading to a reluctance to seek treatment openly. Hormonal treatments for menopause may have adverse side effects, such as increased risk of cancer and heart-related problems, leading to safety concerns among patients. In addition to this, menopause products can be costly, making them inaccessible for some women. Health insurance might not be available for these products. Addressing these issues through education, product improvement, pricing strategies, and strategic marketing can significantly boost the growth of menopause products in the market.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the menopause market evolving?
  • What is driving and restraining the menopause market?
  • How will each menopause submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each menopause submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading menopause markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the menopause projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of menopause projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the menopause market?
  • Where is the menopause market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the menopause market today, and over the next 10 years:

  • Our 253-page report provides 109 tables and 154 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the menopause market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising menopause prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Treatment Type Outlook

  • Dietary Supplements
  • OTC Pharma Products
    • Hormonal
    • Non-Hormonal: Anti-depressants, Others

Distribution Channel

  • Retail
  • Online
  • Institutional Sales

Stage

  • Perimenopause
  • Menopause
  • Post-menopause

Route of Administration

  • Topical
  • Oral
  • Injectables

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 18 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Menopause Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Abbott
  • AbbVie Inc
  • Bayer AG
  • Cipla Inc
  • Eli Lily
  • Emcure
  • Glenmark Pharmaceuticals Limited
  • Merck
  • Novartis
  • Novo Nordisk
  • Padagis
  • Pure Encapsulations, LLC
  • Teva Pharmaceuticals Limited
  • Theramex
  • TherapeuticsMD

Overall world revenue for Menopause Market, 2023 to 2033 in terms of value the market will surpass US$17.33 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Menopause Market, 2023 to 2033 report help you?

In summary, our 250+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Menopause Market, 2023 to 2033 Market, with forecasts for treatment type, distribution channel, stage, route of administration, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 18 key national markets - See forecasts for the Menopause Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Argentina, Germany, France, UK, Italy, Russia, China, India, Japan, South Korea and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Menopause Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Menopause Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Menopause Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings

4 Market Overview

  • 4.1 Key Findings
  • 4.2 Market Dynamics
    • 4.2.1 Market Driving Factors
      • 4.2.1.1 The incidence of vasomotor symptoms associated with menopause is on the rise
      • 4.2.1.2 An increase in investment in menopausal treatments
      • 4.2.1.3 The benefits of dietary supplements are becoming increasingly apparent as more and more research is being conducted
    • 4.2.2 Market Restraining Factors
      • 4.2.2.1 Side effects associated with hormone therapy
      • 4.2.2.2 Limited research and development activities
    • 4.2.3 Market Opportunities
      • 4.2.3.1 Start-up companies have a great opportunity
      • 4.2.3.2 Stress and trendy lifestyles have a negative impact on women's health, creating an opportunity for menopause product manufacturer
  • 4.3 COVID-19 Impact Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Supplier Power
    • 4.4.2 Buyer Power
    • 4.4.3 Competitive Rivalry
    • 4.4.4 Threat from Substitutes
    • 4.4.5 Threat of New Entrants
  • 4.5 PESTLE Analysis

5 Menopause Market Analysis by Treatment

  • 5.1 Key Findings
  • 5.2 Treatment Segment Growth Prospects
  • 5.3 Menopause Market Share by Type, 2023, 2028 & 2033
  • 5.4 Dietary supplements
    • 5.4.1 Dietary Supplements Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.4.2 Dietary Supplements Market Share by Region, 2023-2033 (%)
  • 5.5 OTC Pharma Products
    • 5.5.1 OTC Pharma Products Market Forecast by Region, 2023-2033 (US$ Bn)
    • 5.5.2 OTC Pharma Products Market Share by Region, 2023-2033 (%)
    • 5.5.3 Hormonal
      • 5.5.3.1 Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
      • 5.5.3.2 Hormonal Market Share by Region, 2023-2033 (%)
    • 5.5.4 Non-Hormonal
      • 5.5.4.1 Non-Hormonal Market Forecast by Region, 2023-2033 (US$ Bn)
      • 5.5.4.2 Non-Hormonal Market Share by Region, 2023-2033 (%)
    • 5.5.5 Anti-depressants
      • 5.5.5.1 Anti-depressants Market Forecast by Region, 2023-2033 (US$ Bn)

5.5.5.1.1 Antidepressants Market Share by Region, 2023-2033 (%)

      • 5.5.5.2 Others

5.5.5.2.1 Others Market Forecast by Region, 2023-2033 (US$ Bn)

5.5.5.2.2 Others Market Share by Region, 2023-2033 (%)

6 Menopause Market Analysis by Distribution Channel

  • 6.1 Key Findings
  • 6.2 Distribution Channel Segment Growth Prospects
  • 6.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
  • 6.4 Retail
    • 6.4.1 Retail Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.4.2 Retail Market Share by Region, 2023-2033 (%)
  • 6.5 Institutional Sales
    • 6.5.1 Institutional Sales Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.5.2 Institutional Sales Market Share by Region, 2023-2033 (%)
  • 6.6 Online
    • 6.6.1 Online Market Forecast by Region, 2023-2033 (US$ Bn)
    • 6.6.2 Online Market Share by Region, 2023-2033 (%)

7 Menopause Market Analysis by Stage

  • 7.1 Key Findings
  • 7.2 Stage Segment Growth Prospects
  • 7.3 Menopause Market Share by Stage, 2023, 2028 & 2033
  • 7.4 Perimenopause
    • 7.4.1 Perimenopause Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.4.2 Perimenopause Market Share by Region, 2023-2033 (%)
  • 7.5 Menopause
    • 7.5.1 Menopause Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.5.2 Menopause Market Share by Region, 2023-2033 (%)
  • 7.6 Post menopause
    • 7.6.1 Post menopause Market Forecast by Region, 2023-2033 (US$ Bn)
    • 7.6.2 Post Menopause Market Share by Region, 2023-2033 (%)

8 Menopause Market Analysis by Route of Administration

  • 8.1 Key Findings
  • 8.2 Route of Administration Segment Growth Prospects
  • 8.3 Menopause Market Share by Distribution Channel, 2023, 2028 & 2033
  • 8.4 Topical
    • 8.4.1 Topical Market Forecast by Region, 2023-2033 (US$ Bn)
    • 8.4.2 Topical Market Share by Region, 2023-2033 (%)
  • 8.5 Injectable
    • 8.5.1 Injectable Market Forecast by Region, 2023-2033 (US$ Bn)
    • 8.5.2 Injectable Market Share by Region, 2023-2033 (%)
  • 8.6 Oral
    • 8.6.1 Oral Market Forecast by Region, 2023-2033 (US$ Bn)
    • 8.6.2 Oral Market Share by Region, 2023-2033 (%)

9 Menopause Market Analysis by Region

  • 9.1 Key Findings
  • 9.2 Regional Market Size Estimation and Forecast
  • 9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)

10 North America Menopause Market Analysis

  • 10.1 Key Findings
  • 10.2 North America Menopause Market Attractiveness Index
  • 10.3 North America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 10.4 North America Menopause Market Size Estimation and Forecast by Country
  • 10.5 North America Menopause Market Size Estimation and Forecast by Treatment
  • 10.6 North America Menopause Market Size Estimation and Forecast by Distribution Channel
  • 10.7 North America Menopause Market Size Estimation and Forecast by Stage
  • 10.8 North America Menopause Market Size Estimation and Forecast by Route of Administration
  • 10.9 U.S. Menopause Market Analysis
  • 10.10 Canada Menopause Market Analysis

11 Europe Menopause Market Analysis

  • 11.1 Key Findings
  • 11.2 Europe Menopause Market Attractiveness Index
  • 11.3 Europe Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
  • 11.4 Europe Menopause Market Size Estimation and Forecast by Country
  • 11.5 Europe Menopause Market Size Estimation and Forecast by Treatment
  • 11.6 Europe Menopause Market Size Estimation and Forecast by Distribution Channel
  • 11.7 Europe Menopause Market Size Estimation and Forecast by Stage
  • 11.8 Europe Menopause Market Size Estimation and Forecast by Route of Administration
  • 11.9 UK Menopause Market Analysis
  • 11.10 Germany Menopause Market Analysis
  • 11.11 France Menopause Market Analysis
  • 11.12 Italy Menopause Market Analysis
  • 11.13 Spain Menopause Market Analysis
  • 11.14 Russia Menopause Market Analysis
  • 11.15 Rest of Europe Menopause Market Analysis

12 Asia Pacific Menopause Market Analysis

  • 12.1 Key Findings
  • 12.2 Asia Pacific Menopause Market Attractiveness Index
  • 12.3 Asia Pacific Menopause Market by Country, 2023, 2028 & 2033 (US$ Bn)
  • 12.4 Asia Pacific Menopause Market Size Estimation and Forecast by Country
  • 12.5 Asia Pacific Menopause Market Size Estimation and Forecast by Treatment
  • 12.6 Asia Pacific Menopause Market Size Estimation and Forecast by Distribution Channel
  • 12.7 Asia Pacific Menopause Market Size Estimation and Forecast by Stage
  • 12.8 Asia Pacific Menopause Market Size Estimation and Forecast by Route of Administration
  • 12.9 Japan Menopause Market Analysis
  • 12.10 China Menopause Market Analysis
  • 12.11 India Menopause Market Analysis
  • 12.12 Australia Menopause Market Analysis
  • 12.13 South Korea Menopause Market Analysis
  • 12.14 Rest of Asia Pacific Menopause Market Analysis

13 Latin America Menopause Market Analysis

  • 13.1 Key Findings
  • 13.2 Latin America Menopause Market Attractiveness Index
  • 13.3 Latin America Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 13.4 Latin America Menopause Market Size Estimation and Forecast by Country
  • 13.5 Latin America Menopause Market Size Estimation and Forecast by Treatment
  • 13.6 Latin America Menopause Market Size Estimation and Forecast by Distribution Channel
  • 13.7 Latin America Menopause Market Size Estimation and Forecast by Stage
  • 13.8 Latin America Menopause Market Size Estimation and Forecast by Route of Administration
  • 13.9 Brazil Menopause Market Analysis
  • 13.10 Mexico Menopause Market Analysis
  • 13.11 Argentina Menopause Market Analysis
  • 13.12 Rest of Latin America Menopause Market Analysis

14 MEA Menopause Market Analysis

  • 14.1 Key Findings
  • 14.2 MEA Menopause Market Attractiveness Index
  • 14.3 MEA Menopause Market by Country, 2022, 2027 & 2032 (US$ Bn)
  • 14.4 MEA Menopause Market Size Estimation and Forecast by Country
  • 14.5 MEA Menopause Market Size Estimation and Forecast by Treatment
  • 14.6 MEA Menopause Market Size Estimation and Forecast by Distribution Channel
  • 14.7 MEA Menopause Market Size Estimation and Forecast by Stage
  • 14.8 MEA Menopause Market Size Estimation and Forecast by Route of Administration
  • 14.9 GCC Menopause Market Analysis
  • 14.10 South Africa Menopause Market Analysis
  • 14.11 Rest of MEA Menopause Market Analysis

15 Competitive Landscape

  • 15.1 Company Share Analysis
  • 15.2 Strategic Outlook

16 Company Profiles

  • 16.1 Theramex
    • 16.1.1 Company Snapshot
    • 16.1.2 Company Overview
    • 16.1.3 Product Benchmarking
    • 16.1.4 Strategic Outlook
  • 16.2 AbbVie Inc.
    • 16.2.1 Company Snapshot
    • 16.2.2 Company Overview
    • 16.2.3 Financial Analysis
      • 16.2.3.1 Net Revenue, 2019-2021
    • 16.2.4 Product Benchmarking
    • 16.2.5 Strategic Outlook
  • 16.3 Bayer AG
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2018-2021
    • 16.3.4 Product Benchmarking
  • 16.4 Cipla Inc.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Financial Analysis
      • 16.4.3.1 Net Revenue, 2019-2022
    • 16.4.4 Product Benchmarking
    • 16.4.5 Strategic Outlook
  • 16.5 TherapeuticsMD
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2020-2021
    • 16.5.4 Product Benchmarking
    • 16.5.5 Strategic Outlook
  • 16.6 Eli Lilly and Company
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Financial Analysis
      • 16.6.3.1 Net Revenue, 2019-2021
    • 16.6.4 Product Benchmarking
  • 16.7 Emcure
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2019-2021
    • 16.7.4 Product Benchmarking
  • 16.8 Glenmark Pharmaceuticals Limited
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Financial Analysis
      • 16.8.3.1 Net Revenue, 2019-2022
    • 16.8.4 Product Benchmarking
    • 16.8.5 Strategic Outlook
  • 16.9 Merck & Co., Inc.
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Financial Analysis
      • 16.9.3.1 Net Revenue, 2019-2021
    • 16.9.4 Product Benchmarking
  • 16.10 Novartis AG
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Financial Analysis
      • 16.10.3.1 Net Revenue, 2020-2022
    • 16.10.4 Product Benchmarking
  • 16.11 Novo Nordisk A/S
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Financial Analysis
      • 16.11.3.1 Net Revenue, 2019-2022
    • 16.11.4 Product Benchmarking
  • 16.12 Pure Encapsulations, LLC
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Product Benchmarking
  • 16.13 Padagis
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Product Benchmarking
  • 16.14 Teva Pharmaceutical Industries Ltd.
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Financial Analysis
      • 16.14.3.1 Net Revenue, 2019-2021
    • 16.14.4 Product Benchmarking
    • 16.14.5 Strategic Outlook
  • 16.15 Abbott
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Financial Analysis
      • 16.15.3.1 Net Revenue, 2019-2021
    • 16.15.4 Product Benchmarking

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from
  • 17.2 Recommendations for Market Players